WCN25-744 FELZARTAMAB SELECTIVELY AND POTENTLY TARGETS CD38+ ANTIBODY SECRETING CELLS FROM PATIENTS WITH IMMUNE-MEDIATED KIDNEY DISEASES
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-02-01
|
| Series: | Kidney International Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024924023520 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850223727086665728 |
|---|---|
| author | Kristina Ilieva Karin Landgraf Rainer Boxhammer Stefan Steidl Donna Flesher |
| author_facet | Kristina Ilieva Karin Landgraf Rainer Boxhammer Stefan Steidl Donna Flesher |
| author_sort | Kristina Ilieva |
| collection | DOAJ |
| format | Article |
| id | doaj-art-0d877b8337b44edb9d6fc5cf7e614c1c |
| institution | OA Journals |
| issn | 2468-0249 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Kidney International Reports |
| spelling | doaj-art-0d877b8337b44edb9d6fc5cf7e614c1c2025-08-20T02:05:50ZengElsevierKidney International Reports2468-02492025-02-01102S16010.1016/j.ekir.2024.11.330WCN25-744 FELZARTAMAB SELECTIVELY AND POTENTLY TARGETS CD38+ ANTIBODY SECRETING CELLS FROM PATIENTS WITH IMMUNE-MEDIATED KIDNEY DISEASESKristina Ilieva0Karin Landgraf1Rainer Boxhammer2Stefan Steidl3Donna Flesher4Translational Research, MorphoSys AG, Planegg, GermanyTranslational Research, MorphoSys AG, Planegg, GermanyClinical Biomarker & CDx, MorphoSys AG, Planegg, GermanyTranslational Research, MorphoSys AG, Planegg, GermanyBiomarker and Bioanalytical Sciences, Human Immunology Biosciences, Inc., a Biogen company, South San Francisco, United Stateshttp://www.sciencedirect.com/science/article/pii/S2468024924023520 |
| spellingShingle | Kristina Ilieva Karin Landgraf Rainer Boxhammer Stefan Steidl Donna Flesher WCN25-744 FELZARTAMAB SELECTIVELY AND POTENTLY TARGETS CD38+ ANTIBODY SECRETING CELLS FROM PATIENTS WITH IMMUNE-MEDIATED KIDNEY DISEASES Kidney International Reports |
| title | WCN25-744 FELZARTAMAB SELECTIVELY AND POTENTLY TARGETS CD38+ ANTIBODY SECRETING CELLS FROM PATIENTS WITH IMMUNE-MEDIATED KIDNEY DISEASES |
| title_full | WCN25-744 FELZARTAMAB SELECTIVELY AND POTENTLY TARGETS CD38+ ANTIBODY SECRETING CELLS FROM PATIENTS WITH IMMUNE-MEDIATED KIDNEY DISEASES |
| title_fullStr | WCN25-744 FELZARTAMAB SELECTIVELY AND POTENTLY TARGETS CD38+ ANTIBODY SECRETING CELLS FROM PATIENTS WITH IMMUNE-MEDIATED KIDNEY DISEASES |
| title_full_unstemmed | WCN25-744 FELZARTAMAB SELECTIVELY AND POTENTLY TARGETS CD38+ ANTIBODY SECRETING CELLS FROM PATIENTS WITH IMMUNE-MEDIATED KIDNEY DISEASES |
| title_short | WCN25-744 FELZARTAMAB SELECTIVELY AND POTENTLY TARGETS CD38+ ANTIBODY SECRETING CELLS FROM PATIENTS WITH IMMUNE-MEDIATED KIDNEY DISEASES |
| title_sort | wcn25 744 felzartamab selectively and potently targets cd38 antibody secreting cells from patients with immune mediated kidney diseases |
| url | http://www.sciencedirect.com/science/article/pii/S2468024924023520 |
| work_keys_str_mv | AT kristinailieva wcn25744felzartamabselectivelyandpotentlytargetscd38antibodysecretingcellsfrompatientswithimmunemediatedkidneydiseases AT karinlandgraf wcn25744felzartamabselectivelyandpotentlytargetscd38antibodysecretingcellsfrompatientswithimmunemediatedkidneydiseases AT rainerboxhammer wcn25744felzartamabselectivelyandpotentlytargetscd38antibodysecretingcellsfrompatientswithimmunemediatedkidneydiseases AT stefansteidl wcn25744felzartamabselectivelyandpotentlytargetscd38antibodysecretingcellsfrompatientswithimmunemediatedkidneydiseases AT donnaflesher wcn25744felzartamabselectivelyandpotentlytargetscd38antibodysecretingcellsfrompatientswithimmunemediatedkidneydiseases |